Medtronic Financial Statements From 2010 to 2024
| 2M6 Stock | EUR 81.65 0.72 0.89% |
Check Medtronic PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medtronic PLC's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medtronic financial statements analysis is a perfect complement when working with Medtronic PLC Valuation or Volatility modules.
Medtronic |
Medtronic PLC Company Current Valuation Analysis
Medtronic PLC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medtronic PLC Current Valuation | 113.84 B |
Most of Medtronic PLC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medtronic PLC has a Current Valuation of 113.84 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
Medtronic PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtronic PLC's current stock value. Our valuation model uses many indicators to compare Medtronic PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic PLC competition to find correlations between indicators driving Medtronic PLC's intrinsic value. More Info.Medtronic PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medtronic PLC is roughly 1.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medtronic PLC's earnings, one of the primary drivers of an investment's value.About Medtronic PLC Financial Statements
Medtronic PLC stakeholders use historical fundamental indicators, such as Medtronic PLC's revenue or net income, to determine how well the company is positioned to perform in the future. Although Medtronic PLC investors may analyze each financial statement separately, they are all interrelated. For example, changes in Medtronic PLC's assets and liabilities are reflected in the revenues and expenses on Medtronic PLC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Medtronic PLC. Please read more on our technical analysis and fundamental analysis pages.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC PLC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101013 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out the analysis of Medtronic PLC Correlation against competitors. For more detail on how to invest in Medtronic Stock please use our How to Invest in Medtronic PLC guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.